We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Richard Pratley MD

Richard E. Pratley MD

Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute, Orlando, Florida; Medical Director, AdventHealth Diabetes Institute, Orlando, Florida; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Richard Pratley, an internationally recognized expert in diabetes, is Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute and Medical Director of the AdventHealth Diabetes Institute in Orlando, as well as Adjunct Professor of Medicine, Johns Hopkins University School of Medicine.

Dr. Pratley is a principal investigator for both NIH- and pharmaceutical company–sponsored trials in diabetes and obesity. His current research interests include the prevention of diabetes, improving the care of older individuals with diabetes, developing new drugs to treat and prevent diabetes and its complications, understanding the role of the fat cell in increasing the risk for diabetes and heart disease, and investigating extracellular vesicles in inter-cellular and inter-organ cross-talk. He presents his research regularly at national and international meetings and has written over 300 peer-reviewed articles. He is a member of the American Diabetes Association and the European Association for the Study of Diabetes. He has served on the editorial boards of a number of high impact journals, including Diabetes Care, The Lancet Diabetes and Endocrinology, The Journal of Clinical Endocrinology & Metabolism, and the Journal of Diabetes and Its Complications.

After receiving his medical degree from Wayne State University in Detroit and undergoing residency training in internal medicine the University of Michigan in Ann Arbor, he completed fellowships in geriatric medicine and gerontology at the University of Michigan, Johns Hopkins University, and the National Institute on Aging.

Positions:
Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute; Medical Director, AdventHealth Diabetes Institute; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine

Degrees:
MD: Wayne State University, Detroit, Michigan

Postgraduate Training:
Fellowship (geriatric medicine and gerontology): University of Michigan, Johns Hopkins University, National Institute on Aging

Research Interests:
Prevention of diabetes; improving the care of older individuals with diabetes; developing new drugs to treat and prevent diabetes and its complications; understanding the role of the fat cell in increasing the risk for diabetes and heart disease; investigating extracellular vesicles in inter-cellular and inter-organ cross-talk.

Disclosures

Dr. Pratley reports consulting fees from Bayer AG; consulting fees from Gasherbrum Bio, Inc.; consulting fees from Hengrui (USA) Ltd.; consulting fees from Merck; grants, speaker fees and consulting fees from Novo Nordisk; consulting fees from Rivus Pharmaceuticals Inc.; consulting fees from Sun Pharmaceutical Industries. Dr. Richard Pratley's services were paid for directly to AdventHealth, a nonprofit organization.